Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Article   |    
Am J Psychiatry 1964;120:1166-1169.
View Author and Article Information

Electrical Engineer, Seattle Development Laboratory, Minneapolis-Honeywell Regulator Co., Seattle, Wash.

text A A A
PDF of the full text article.

The present study is directed toward investigating whether the hyperponesis found in schizophrenics plays some type of etiologic role in the schizophrenic process or is merely a consequence of the disorder. Hyperponesis is a neurophysiologic state measurable electromyographically.Four schizophrenic patients were followed chronologically by means of serial multi-channel integrated EMGs so that time relationships between neurophysiologic state and clinical condition could be determined. Results were analyzed statistically.It was found that schizophrenics in remission exhibited an intermittent hyperponesis whose lability increased and/or baseline rose prior to relapse. A persistent hyperponesis was present during the exacerbation. A reduction in the hyperponesis, whether chlorpromazine-induced or spontaneous, was followed by improvement in the patient's clinical condition.After a consideration of several possibilities and the available evidence, the followig hypothesis was suggested: Hyperponesis is a form of energy expenditure within the nervous system, a way of reacting to environment and self, that has detrimental effects on nervous system function. It can trigger a schizophrenic exacerbation in a nervous system prone to schizophrenic reactions through inherited or acquired characteristics. When the hyperponesis is diminished adequately, by whatever means, the nervous system is freed from this deleterious influence and can return to a state of better functioning.

Abstract Teaser
Figures in this Article


Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).




CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Web of Science® Times Cited: 8

Related Content
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 9.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 6.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 10.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
APA Guidelines
PubMed Articles